1,088 results on '"transplant recipient"'
Search Results
2. Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients (COVIDSOT)
- Author
-
Spanish Network for Research in Infectious Diseases and Grupo de Estudio de la Infección en el Trasplante (GESITRA)
- Published
- 2024
3. Atypical posterior reversible encephalopathy syndrome: A lentiform fork sign following transplantation.
- Author
-
Appiani, Franco E., Claverie, Carlos S., and Klein, Francisco R.
- Subjects
- *
POSTERIOR leukoencephalopathy syndrome , *SYMPTOMS , *CEREBRAL edema , *CORPUS striatum , *ENDOTHELIUM diseases - Abstract
Key Clinical Message: Posterior Reversible Encephalopathy Syndrome, typically characterized by parieto‐occipital vasogenic edema, can present atypically, as a bilateral symmetrical vasogenic edema in the basal ganglia, featuring the called "lentiform fork sign." Prompt recognition of such variations is crucial for accurate diagnosis and tailored management, highlighting the complexity of this syndrome's manifestations. Posterior Reversible Encephalopathy Syndrome (PRES) manifests as transient neurological symptoms and cerebral edema, commonly associated with immunosuppressive drugs (ISDs) in transplant recipients. ISDs can lead to endothelial dysfunction and compromise the blood–brain barrier. Typically, PRES exhibits identifiable MRI patterns, often demonstrating vasogenic edema in the bilateral parieto‐occipital white matter. Identifying unique presentations, such as the recently observed "lentiform fork sign," commonly seen in uremic encephalopathy, emphasizes this syndrome's broad spectrum manifestations. A 19‐year‐old male, who underwent bilateral lung and liver transplantation, experienced a bilateral tonic–clonic seizure of unknown onset 47 days post‐surgery. MRI findings revealed an unconventional PRES pattern, featuring the "lentiform fork sign" as bilateral symmetrical vasogenic edema in the basal ganglia, surrounded by a hyperintense rim outlining the lentiform nucleus bilaterally. Subsequent management, including ISD modification and magnesium supplementation, resulted in clinical and neuroimaging resolution. An almost complete clinical and radiological resolution was achieved after 14 days. The occurrence of PRES in transplant recipients highlights the intricate interplay among ISDs, physiological factors, and cerebrovascular dynamics, potentially involving direct neurovascular endothelial toxicity and disruption of the blood–brain barrier. Neuroimaging plays a pivotal role in diagnosis. The distinctive "lentiform fork sign" was observed in this patient despite the absence of typical metabolic disturbances. Management strategies usually involve reducing hypertension, discontinuing ISDs, correcting electrolyte imbalances, and initiating antiseizure drugs if necessary. Identifying the presence of the "lentiform fork sign" alongside typical PRES edema in a patient lacking renal failure emphasizes that this manifestation is not solely indicative of uremic encephalopathy. Instead, it might represent the final common pathway resulting from alterations in the blood–brain barrier integrity within the deep white matter. Understanding such atypical imaging manifestations could significantly aid earlier and more precise diagnosis, influencing appropriate management decisions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Identity Disclosure Between Donor Family Members and Organ Transplant Recipients: A Description and Synthesis of Australian Laws and Guidelines.
- Author
-
Cignarella, Anthony, Marshall, Andrea, Ranse, Kristen, Opdam, Helen, Buckley, Thomas, and Hewitt, Jayne
- Subjects
- *
MEDICAL ethics laws , *FAMILIES & psychology , *RIGHT of privacy , *MEDICAL protocols , *PATIENTS , *TRANSPLANTATION of organs, tissues, etc. , *PRIVACY , *PATIENT-family relations , *ORGAN donation , *INTERPERSONAL relations , *HOSPITAL laws , *ORGAN transplant coordinators , *MEDICAL ethics - Abstract
Introduction: The disclosure of information that identifies deceased organ donors and/or organ transplant recipients by organ donation agencies and transplant centres is regulated in Australia by state and territory legislation, yet a significant number of donor family members and transplant recipients independently establish contact with each other. Aim: To describe and synthesize Australian laws and guidelines on the disclosure of identifying information. Method: Legislation and guidelines relevant to organ donation and transplantation were obtained following a search of government and DonateLife network websites. Information about the regulation of identity disclosure was extracted and synthesised using a process guided by Walt and Gilson's (1994) policy analysis framework. Findings: Nineteen documents were examined. Six guidelines refer to and were consistent with current legislation. Four documents did not address identity disclosure. All jurisdictions prohibit healthcare professionals from disclosing identifying information. In three states, the prohibition extends to all members of the public including donor family members and transplant recipients. Conclusion: Restrictions on identity disclosure have implications for public promotion of donation and transplantation where sharing of stories and images of organ donors and transplant recipients is common. Further research is required to understand the perspective of donor family members, transplant recipients, and healthcare professionals impacted by the current laws. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Atypical posterior reversible encephalopathy syndrome: A lentiform fork sign following transplantation
- Author
-
Franco E. Appiani, Carlos S. Claverie, and Francisco R. Klein
- Subjects
brain edema ,immunosuppressive drugs (ISDs) ,lentiform fork sign ,reversible posterior encephalopathy syndrome (PRES) ,seizures ,transplant recipient ,Medicine ,Medicine (General) ,R5-920 - Abstract
Key Clinical Message Posterior Reversible Encephalopathy Syndrome, typically characterized by parieto‐occipital vasogenic edema, can present atypically, as a bilateral symmetrical vasogenic edema in the basal ganglia, featuring the called “lentiform fork sign.” Prompt recognition of such variations is crucial for accurate diagnosis and tailored management, highlighting the complexity of this syndrome's manifestations. Abstract Posterior Reversible Encephalopathy Syndrome (PRES) manifests as transient neurological symptoms and cerebral edema, commonly associated with immunosuppressive drugs (ISDs) in transplant recipients. ISDs can lead to endothelial dysfunction and compromise the blood–brain barrier. Typically, PRES exhibits identifiable MRI patterns, often demonstrating vasogenic edema in the bilateral parieto‐occipital white matter. Identifying unique presentations, such as the recently observed “lentiform fork sign,” commonly seen in uremic encephalopathy, emphasizes this syndrome's broad spectrum manifestations. A 19‐year‐old male, who underwent bilateral lung and liver transplantation, experienced a bilateral tonic–clonic seizure of unknown onset 47 days post‐surgery. MRI findings revealed an unconventional PRES pattern, featuring the “lentiform fork sign” as bilateral symmetrical vasogenic edema in the basal ganglia, surrounded by a hyperintense rim outlining the lentiform nucleus bilaterally. Subsequent management, including ISD modification and magnesium supplementation, resulted in clinical and neuroimaging resolution. An almost complete clinical and radiological resolution was achieved after 14 days. The occurrence of PRES in transplant recipients highlights the intricate interplay among ISDs, physiological factors, and cerebrovascular dynamics, potentially involving direct neurovascular endothelial toxicity and disruption of the blood–brain barrier. Neuroimaging plays a pivotal role in diagnosis. The distinctive “lentiform fork sign” was observed in this patient despite the absence of typical metabolic disturbances. Management strategies usually involve reducing hypertension, discontinuing ISDs, correcting electrolyte imbalances, and initiating antiseizure drugs if necessary. Identifying the presence of the “lentiform fork sign” alongside typical PRES edema in a patient lacking renal failure emphasizes that this manifestation is not solely indicative of uremic encephalopathy. Instead, it might represent the final common pathway resulting from alterations in the blood–brain barrier integrity within the deep white matter. Understanding such atypical imaging manifestations could significantly aid earlier and more precise diagnosis, influencing appropriate management decisions.
- Published
- 2024
- Full Text
- View/download PDF
6. Case Report: Severe Diarrhea Caused by Cryptosporidium Diagnosed by Metagenome Next-Generation Sequencing in Blood
- Author
-
Shan H, Wei C, Zhang J, He M, and Zhang Z
- Subjects
nitazoxanide ,cryptosporidiosis ,cryptosporidium ,transplant recipient ,azithromycin ,Infectious and parasitic diseases ,RC109-216 - Abstract
Huifang Shan,1 Chunyan Wei,1 Jingyi Zhang,1 Min He,2 Zhongwei Zhang2 1Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, People’s Republic of China; 2Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, People’s Republic of ChinaCorrespondence: Zhongwei Zhang, Email 716461751@qq.comBackground: Cryptosporidium is one of the major pathogens causing diarrhea worldwide. At present, cryptosporidiosis is difficult to prevent and control, especially in immunocompromised hosts. It may cause life-threatening diarrhea and malabsorption among children and immunocompromised patients. Therefore, it is very important to explore rapid diagnostic tools and treatment methods for Cryptosporidium infection.Case Presentation: We reported a case of severe diarrhea caused by cryptosporidiosis in a liver transplant recipient, whose condition was finally confirmed by metagenomic next-generation sequencing (mNGS) and fecal microscopy. His illness was resolved with immunosuppression regulation, nitazoxanide administration, and infection control.Conclusion: So far, nitazoxanide is still the first choice for the treatment of cryptosporidiosis. Our institutional experience suggested that nitazoxanide alone may be effective on the basis of adjusting immunosuppressant. In addition, even though diagnosis of Cryptosporidium infection is a challenge, mNGS can serve as a rapid screening tool in low-prevalence setting.Keywords: nitazoxanide, cryptosporidiosis, Cryptosporidium, transplant recipient, azithromycin
- Published
- 2023
7. Characterization of the stanford integrated psychosocial assessment for transplant for heart, liver, and kidney transplant candidates in Japan
- Author
-
Kosuke Takano, Hidehiro Oshibuchi, Sayaka Kobayashi, Junko Tsutsui, Satoko Ito, Rumiko Kamba, Rie Akaho, and Katsuji Nishimura
- Subjects
Organ-specific ,Pre-transplant evaluation ,Post-transplant outcomes ,Psychosocial support ,Stanford Integrated Psychosocial Assessment for transplantation ,Transplant recipient ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Abstract Background The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) is a comprehensive psychosocial assessment proven useful for predicting the outcomes of organ transplantation that is expected to be useful in Japan. However, the characteristics of organ-specific SIPAT scores for organ transplant recipient candidates in Japan are unclear and, to date, the SIPAT has not been properly utilized in clinical practice. The purpose of this study was to present basic data that can be used to establish the relation between SIPAT scores and post-transplantation psychosocial outcomes as well as organ-specific outcomes. Methods This study included 167 transplant recipient candidates (25 heart, 71 liver, and 71 kidney) who completed a semi-structured interview based on the Japanese version of SIPAT (SIPAT-J) prior to transplantation. The differences between organs in terms of SIPAT scores and differences in SIPAT scores based on demographic data were comparatively analyzed. Results The total SIPAT scores were higher for liver recipient candidates than for heart recipient candidates (P = .019). Regarding the subscales, SIPAT B (social support system) scores were higher for liver and kidney recipient candidates than for heart recipient candidates (P = .021), whereas SIPAT C (psychological stability and psychopathology) scores were higher for liver recipient candidates than for kidney recipient candidates (P = .002). Recipient candidates with a history of psychiatric treatment and those who were unemployed had higher SIPAT scores, regardless of the transplant organ, than recipient candidates without a history of psychiatric treatment and those who were employed (P
- Published
- 2023
- Full Text
- View/download PDF
8. An unusual case of late, isolated involvement of renal allograft with tuberculosis.
- Author
-
Dalvi, Sayali, Bichu, Shrirang, and Tilve, Parag
- Subjects
TUBERCULOSIS diagnosis ,DRUG therapy for tuberculosis ,APPETITE ,METHYLPREDNISOLONE ,MEROPENEM ,HOMOGRAFTS ,PYELONEPHRITIS ,FEVER ,PREDNISOLONE ,GRAFT rejection ,KIDNEY transplantation ,PATIENTS ,POSITRON emission tomography computed tomography ,MYCOPHENOLIC acid ,TREATMENT effectiveness ,TUBERCULOSIS ,IMMUNOSUPPRESSIVE agents ,EARLY diagnosis ,TRANSPLANTATION of organs, tissues, etc. ,TACROLIMUS ,CREATININE ,DRUG administration ,DRUG dosage ,SYMPTOMS - Abstract
Tuberculosis is endemic in India, with a prevalence of 8%–13% in kidney transplant patients. Atypical presentations have been described in immunocompromised individuals, and we present an unusual and rare case of isolated tuberculous involvement of the kidney allograft presenting 6 years posttransplant. Our patient presented with fever, poor appetite, and malaise of very short duration without ongoing weight loss; a normal urine examination as well as ultrasonography of allograft, requiring positron emission tomography-computed tomography to determine the source of infection. A vigilant approach with a high degree of suspicion in this case led to early detection and good outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Time for transplant care professionals to face recipients' fear of graft rejection—an opinion paper
- Author
-
Anna Forsberg, Nichon Jansen, David Paredes, and Hannah Maple
- Subjects
graft rejection ,organ transplantation ,psychological well-being ,uncertainty ,lived experience ,transplant recipient ,Specialties of internal medicine ,RC581-951 - Published
- 2023
- Full Text
- View/download PDF
10. Characterization of the stanford integrated psychosocial assessment for transplant for heart, liver, and kidney transplant candidates in Japan.
- Author
-
Takano, Kosuke, Oshibuchi, Hidehiro, Kobayashi, Sayaka, Tsutsui, Junko, Ito, Satoko, Kamba, Rumiko, Akaho, Rie, and Nishimura, Katsuji
- Subjects
- *
HEART transplantation , *KIDNEY transplantation , *SOCIAL networks , *LIVER , *TRANSPLANTATION of organs, tissues, etc. - Abstract
Background: The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) is a comprehensive psychosocial assessment proven useful for predicting the outcomes of organ transplantation that is expected to be useful in Japan. However, the characteristics of organ-specific SIPAT scores for organ transplant recipient candidates in Japan are unclear and, to date, the SIPAT has not been properly utilized in clinical practice. The purpose of this study was to present basic data that can be used to establish the relation between SIPAT scores and post-transplantation psychosocial outcomes as well as organ-specific outcomes. Methods: This study included 167 transplant recipient candidates (25 heart, 71 liver, and 71 kidney) who completed a semi-structured interview based on the Japanese version of SIPAT (SIPAT-J) prior to transplantation. The differences between organs in terms of SIPAT scores and differences in SIPAT scores based on demographic data were comparatively analyzed. Results: The total SIPAT scores were higher for liver recipient candidates than for heart recipient candidates (P =.019). Regarding the subscales, SIPAT B (social support system) scores were higher for liver and kidney recipient candidates than for heart recipient candidates (P =.021), whereas SIPAT C (psychological stability and psychopathology) scores were higher for liver recipient candidates than for kidney recipient candidates (P =.002). Recipient candidates with a history of psychiatric treatment and those who were unemployed had higher SIPAT scores, regardless of the transplant organ, than recipient candidates without a history of psychiatric treatment and those who were employed (P <.001, P =.016, respectively). Conclusions: There were notable differences in the total SIPAT-J and subscale scores among the liver, heart, and kidney recipient candidates. Each organ was associated with specific psychosocial issues that should be addressed before transplantation. Interventions such as information provision and patient education based on SIPAT assessment results for each organ may improve recipient post-transplant outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Identity disclosure between donor families and organ transplant recipients: an integrative review of the international literature.
- Author
-
Cignarella, Anthony, Ranse, Kristen, Hewitt, Jayne, Opdam, Helen, Romero, Lorena, and Marshall, Andrea
- Subjects
- *
CINAHL database , *PSYCHOLOGY information storage & retrieval systems , *PROFESSIONAL peer review , *MEDICAL information storage & retrieval systems , *SYSTEMATIC reviews , *PATIENTS , *FAMILIES , *SELF-disclosure , *MEDLINE , *EMOTIONS , *ORGAN donation , *TRANSPLANTATION of organs, tissues, etc. - Abstract
Anonymity of deceased organ donation is a legal requirement in many international jurisdictions where legislation prohibits health professionals from disclosing identifiable information about donors, recipients or their families. Written correspondence between donor families and transplant recipients that is coordinated by healthcare professionals must remain anonymous. Internationally, an increasing number of donor families and transplant recipients have advocated for law reform and policy amendment to enable the exchange of identifiable written correspondence and/or face-to-face meetings. This paper aims to synthesise and critically evaluate published, peer-reviewed literature on the perceptions, benefits and challenges of identifiable communication or anonymity between donor families and organ transplant recipients in the international context. Analysis of the findings revealed two major themes: (1) views held by donor families, transplant recipients and healthcare professionals towards identity disclosure in the context of organ donation are diverse across and within groups (2) there are benefits and burdens associated with connecting donor families and transplant recipients through written correspondence. Less is known about the impact of face-to-face meetings between donor families and transplant recipients. However, what is known is that for some donor families, meeting with the transplant recipient(s) may provide a range of positive emotions. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Immunosuppressed patients are at increased risk of local recurrence, metastasis, and disease specific death from cutaneous squamous cell carcinoma.
- Author
-
Lopez, Adriana, Babadzhanov, Marianna, Cheraghlou, Shayan, Canavan, Theresa, Doudican, Nicole, Stevenson, Mary, and Carucci, John A.
- Subjects
- *
IMMUNOCOMPROMISED patients , *SQUAMOUS cell carcinoma , *METASTASIS - Abstract
It is well established that immunosuppressed patients are at increased risk for poor outcomes (PO) from cutaneous squamous cell carcinoma (cSCC), including local recurrence (LR), nodal metastasis (NM), distant metastasis (DM), and disease-specific death (DSD). Defining PO risk is challenging but may be beneficial in guiding management. We aimed to define PO risk factors and evaluated their importance in immunosuppressed versus immunocompetent patients. We conducted a 4-year single-center retrospective review of patients with cSCC. Patient and tumor characteristics were evaluated in those that experienced PO. Immunosuppressed patients were ~ 11-fold more likely than immunocompetent patients to develop PO (10/85 vs. 15/1332, p < 0.0001). Among those with PO, immunosuppressed patients had diminished relapse free (p = 0.026) and progression free (p < 0.001) survival compared to immunocompetent. Immunosuppression was significantly associated with LR (p < 0.00001). Immunosuppressed patients were also more likely to develop NM, DM and experience DSD (p = 0.027). Mohs Appropriate Use Criteria was associated with NM, DM and DSD (p = 0.029), with area H tumors more likely to result in metastasis and death. In conclusion, immunosuppressed patients are more likely to develop LR, metastasis, and DSD from cSCC compared to immunocompetent patients. Immunosuppressed status was an independent risk factor for PO in this cohort and further considered for its inclusion in prognostication schema is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. An unusual case of late, isolated involvement of renal allograft with tuberculosis
- Author
-
Sayali Dalvi, Shrirang Bichu, and Parag Vasant Tilve
- Subjects
renal allograft ,transplant recipient ,tuberculosis ,Surgery ,RD1-811 - Abstract
Tuberculosis is endemic in India, with a prevalence of 8%–13% in kidney transplant patients. Atypical presentations have been described in immunocompromised individuals, and we present an unusual and rare case of isolated tuberculous involvement of the kidney allograft presenting 6 years posttransplant. Our patient presented with fever, poor appetite, and malaise of very short duration without ongoing weight loss; a normal urine examination as well as ultrasonography of allograft, requiring positron emission tomography-computed tomography to determine the source of infection. A vigilant approach with a high degree of suspicion in this case led to early detection and good outcomes.
- Published
- 2023
- Full Text
- View/download PDF
14. Prospective comparison of suture ligation and electrothermal sealing for the control of perivascular lymphatics in kidney transplant recipients
- Author
-
Ketan Mehra, Kushal Kapashi, Sajni Khemchandani, Pranjal Ramanlal Modi, and Syed Jamal Rizvi
- Subjects
lymphocele ,renal transplant ,transplant recipient ,kidney transplantation ,Medical technology ,R855-855.5 - Abstract
Background : The use of sutures as ligatures has proven to be safe and reliable for the control of lymphatic vessels. The electrothermal bipolar vessel sealer (EBVS) is a relatively new type of device that can be used to seal lymphatics. We conducted a study to evaluate the safety and efficacy of EBVS for preparation of the recipient vessel during renal transplantation. Methods : In this prospective randomized controlled study, EBVS (Medtronic) was compared with conventional ligature for the control of perivascular lymphatics in kidney transplant recipients. A total of 52 kidney transplant recipients were randomly assigned to two groups. In group 1, EBVS was used to control perivascular lymphatics, while conventional silk ligatures were used in group 2. Demographic characteristics, as well as preoperative, perioperative, and postoperative variables, were noted and compared between the groups. Results : The mean recipient vessel preparation time was 8.3±1.9 minutes in group 1 and 14.5±4 minutes in group 2 (P
- Published
- 2022
- Full Text
- View/download PDF
15. Systematic review of programmed cell death-1 inhibitor therapy for advanced-stage cutaneous squamous cell carcinoma in solid-organ transplant recipients
- Author
-
Hannah L. Hanania and Daniel J. Lewis
- Subjects
cutaneous squamous cell carcinoma ,solid organ transplant ,anti-pd-1 ,checkpoint inhibitor ,transplant recipient ,Dermatology ,RL1-803 - Abstract
Background Programmed cell death-1 (PD-1) inhibitors represent an effective treatment option for advanced cutaneous squamous cell carcinoma (cSCC). However, solid organ transplant (SOT) recipients with cSCC have traditionally been excluded from clinical trials. Objective To assess the safety and efficacy of PD-1 inhibitors for stage III-IV cSCC in SOT recipients. Materials & Methods A systematic review was performed using the PubMed, EMBASE, and Scopus databases. Results We identified 21 articles describing 33 SOT recipients (26 kidney, four liver, two lung, and one heart) with stage III-IV cSCC treated with PD-1 inhibitors. Eleven patients (33.3%) experienced allograft rejection. Of the 25 cases with iRECIST scores, twelve patients (48.0%) had a complete response (CR), eight (32.0%) showed a partial response (PR), three (12.0%) progressive disease, and two (8.0%) stable disease (SD). Including patients without available iRECIST scores, 21 patients (63.6%) showed tumor response. Eleven patients died, with six (54.5%) due to tumor progression and one (9.1%) due to allograft rejection after foregoing dialysis. Conclusion PD-1 inhibitors demonstrate efficacy for advanced cSCC and confer a risk of allograft rejection in SOT recipients, requiring careful assessment of risks and benefits. If anti-PD-1 therapy is pursued, use of mTOR inhibitors, prophylactic steroids, and donor-derived cell-free DNA monitoring may mitigate the risk of rejection.
- Published
- 2022
- Full Text
- View/download PDF
16. Considerations on the Relationship Between Living Organ Donor and Recipient
- Author
-
Golden, Lessie Eric, Zimbrean, Paula C., editor, Sher, Yelizaveta, editor, Crone, Catherine, editor, and DiMartini, Andrea F., editor
- Published
- 2022
- Full Text
- View/download PDF
17. Recipient Management before Lung Transplantation
- Author
-
Hyoung Soo Kim and Sunghoon Park
- Subjects
lung transplantation ,management ,transplant recipient ,Medicine (General) ,R5-920 - Abstract
Lung transplantation is considered a viable treatment option for patients with end-stage lung disease. Recent decades have seen a gradual increase in the number of lung transplantation patients worldwide, and in South Korea, the case number has increased at least 3-fold during the last decade. Furthermore, the waiting list time is becoming longer, and more elderly patients (>65 years) are undergoing lung transplantation; that is, the patients placed on the waiting list are older and sicker than in the past. Hence, proper management during the pre-transplantation period, as well as careful selection of candidates, is a key factor for transplant success and patient survival. Although referring and transplant centers should address many issues, the main areas of focus should be the timing of referral, nutrition, pulmonary rehabilitation, critical care (including mechanical ventilation and extracorporeal membrane oxygenation), psychological support, and the management of preexisting comorbid conditions (coronary artery disease, diabetes mellitus, gastroesophageal reflux disease, osteoporosis, malignancy, viral infections, and chronic infections). In this context, the present article reviews and summarizes the pre-transplantation management strategies for adult patients listed for lung transplantation.
- Published
- 2022
- Full Text
- View/download PDF
18. COVID-19 Infection in Renal Transplant Recipients at Dubai Hospital: Incidence, Clinical Profile, and Outcome
- Author
-
Kashif Gulzar, Fakhriya Alalawi, Dileep Nanik Ram Kumar, Hebah Rami Al Jaghoub, and Amna Khalifa Alhadari
- Subjects
transplant recipient ,acute kidney injury ,acute respiratory distress syndrome ,coronavirus disease ,in-hospital mortality ,Medicine - Abstract
Background: Renal transplant recipients are at risk to acquire COVID-19 infection quite frequently, owing to their immunocompromized state. Nevertheless, data on the effects of this infection on patients and graft function are sparse from the Arab world. Methods: This retrospective cohort study was conducted in Dubai Hospital from April 1, 2020, to August 1, 2021. We analyzed 42 COVID-19-positive renal transplant recipients’ data. Information concerning demographics, comorbidities, medications, clinical and laboratory data, and outcomes was collected from the electronic medical records. Univariate analyses were performed to determine the association of acute kidney injury (AKI) with in-hospital mortality. Results: Median age was 47.46 (17–66) years; about 59% of patients were male. Eleven (26.19%) patients developed AKI during hospitalization. On admission high ferritin, C-reactive protein, creatinine, and low absolute lymphocyte count are identified risk factors for in-hospital AKI. Seven (21.87%) patients had their calcineurin inhibitor levels touch a toxic peak possibly due to an interaction with antivirals. Mortality was 14.28%, and the same number of patients required mechanical ventilation during treatment. Conclusion: A significant number of renal transplant recipients suffered from AKI during COVID-19 infection, and the mortality rate in this study population was less than in studies from other countries in the region. More insights are required to manage this infection in renal transplant recipients.
- Published
- 2022
- Full Text
- View/download PDF
19. Impact of donor-to-recipient weight ratio on the hospital outcomes of pediatric heart transplantation
- Author
-
Mohammad Mahdavi, Tahmineh Tahouri, Avisa Tabib, Hooman Bakhshandeh, Ali Sadeghpour-Tabaei, Hossein Shahzadi, and Nader Harooni
- Subjects
Cardiac transplantation ,Donor selection ,Transplant recipient ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Identifying the factors that can influence the prognosis and final outcomes of pediatric heart transplantation is important and makes it possible to prevent complications and improve outcomes. Coordination of donor characteristics with the recipient in terms of sex, weight, body mass index (BMI), and body surface area (BSA) is an important factor that can influence the outcome of the transplantation. There is still no consensus regarding the role of discrepancy in anthropometrics between donors and recipients. The aim of this study was to investigate the relationship between donor and recipient weight mismatch on the early outcomes of pediatric heart transplantation. In this historical cohort study, 80 children who had underwent heart transplantation for the first time between 2014 and 2019 in Shahid Rajaie Cardiovascular Medical and Research Center in Tehran, Iran, were enrolled and divided into three groups according to donor-to-recipient weight ratio (0.8
- Published
- 2022
- Full Text
- View/download PDF
20. Factors Affecting the Quality of Life of Patients After Kidney Transplantation: A Cross-Sectional Study
- Author
-
Maruhum Bonar Hasiholan Marbun, Dories Septiana, Hamzah Shatri, and Ikhwan Rinaldi
- Subjects
kidney transplantation ,mental aspect ,physical aspect ,quality of life ,transplant recipient ,Internal medicine ,RC31-1245 - Abstract
Background: Kidney transplantation is currently the best choice for renal replacement therapy, due to its effect in reducing mortality and improving the quality of life (QoL) of patients with end-stage renal disease. This study aimed to identify factors affecting QoL after kidney transplantation. Methods: We conducted a cross sectional study by recruiting patients who had kidney transplantation at Cipto Mangunkusumo General Hospital, Jakarta, Indonesia, from 2018 – 2020. QoL was assessed using the 36-item Short Form Health Survey (SF-36) questionnaire. We evaluated age, sex, body mass index, hemoglobin level, estimated glomerular filtration rate, duration of dialysis before transplantation, history of diabetes, depression, and performance status as factors associated with QoL score. Results: We involved 107 subjects in our study. Depression, hemoglobin level, ECOG performance status, and duration of dialysis were factors affecting the physical component score (R2=0.21). Depression and hemoglobin level were factors affecting the mental component score (R2=0.34 ). Depression, hemoglobin level, and ECOG performance status were factors contributed to the total QoL score (R2=0.41). Conclusion: Factors that contributed to QoL status were depression, ECOG performance status, and hemoglobin levels. This study supported the need for assessment of QoL on regular basis, psychological aspects including depression, as well as other factors that can affect QoL such as performance status and hemoglobin level in patients before and after kidney transplantations.
- Published
- 2023
21. Organ transplant status, anatomic location, and age impact rates of adnexal involvement of actinic keratoses.
- Author
-
McEwen, Matthew W., Tirado, Mariantonieta, Lipman, Sonja, Patel, Tejesh, and Jones, Allison
- Subjects
- *
TRANSPLANTATION of organs, tissues, etc. , *KERATOSIS , *SQUAMOUS cell carcinoma , *FOLLICULAR dendritic cells , *ACTINIC keratosis - Abstract
Actinic keratoses (AKs) are pre‐malignant skin lesions that can give rise to squamous cell carcinomas. Involvement of adnexal structures by AKs has been postulated to confer resistance to therapy and facilitate malignant progression. In our study, we identified several factors associated with increased risk of adnexal involvement of AKs. We found an increased risk of follicular involvement in AKs on the head and neck, a slightly increased risk of eccrine involvement with increasing age, and an increased risk of eccrine involvement in organ transplant patients. Additionally, our data showed a higher overall rate of follicular involvement of AKs than previously reported. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Systematic review of programmed cell death-1 inhibitor therapy for advanced-stage cutaneous squamous cell carcinoma in solid-organ transplant recipients.
- Author
-
Hanania, Hannah L. and Lewis, Daniel J.
- Subjects
- *
SQUAMOUS cell carcinoma , *GRAFT rejection , *TRANSPLANTATION of organs, tissues, etc. , *CELL-free DNA , *EVEROLIMUS , *PROGRAMMED cell death 1 receptors , *KIDNEY failure - Abstract
Programmed cell death-1 (PD-1) inhibitors represent an effective treatment option for advanced cutaneous squamous cell carcinoma (cSCC). However, solid organ transplant (SOT) recipients with cSCC have traditionally been excluded from clinical trials. To assess the safety and efficacy of PD-1 inhibitors for stage III-IV cSCC in SOT recipients. A systematic review was performed using the PubMed, EMBASE, and Scopus databases. We identified 21 articles describing 33 SOT recipients (26 kidney, four liver, two lung, and one heart) with stage III-IV cSCC treated with PD-1 inhibitors. Eleven patients (33.3%) experienced allograft rejection. Of the 25 cases with iRECIST scores, twelve patients (48.0%) had a complete response (CR), eight (32.0%) showed a partial response (PR), three (12.0%) progressive disease, and two (8.0%) stable disease (SD). Including patients without available iRECIST scores, 21 patients (63.6%) showed tumor response. Eleven patients died, with six (54.5%) due to tumor progression and one (9.1%) due to allograft rejection after foregoing dialysis. PD-1 inhibitors demonstrate efficacy for advanced cSCC and confer a risk of allograft rejection in SOT recipients, requiring careful assessment of risks and benefits. If anti-PD-1 therapy is pursued, use of mTOR inhibitors, prophylactic steroids, and donor-derived cell-free DNA monitoring may mitigate the risk of rejection. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. Toxoplasma gondii in Solid Organ and Stem Cell Transplant: Prevention and Treatment
- Author
-
Guegan, Hélène, Robert-Gangneux, Florence, Nelson Kotton, Camille, Section editor, Morris, Michele I., editor, Kotton, Camille Nelson, editor, and Wolfe, Cameron R., editor
- Published
- 2021
- Full Text
- View/download PDF
24. Non-tuberculous mycobacteria infection presenting as a hepatic allograft abscess
- Author
-
Anthony Robateau Colón, Eibhlin Higgins, Nicholas Boire, Nathan Cummins, and Kymberly D. Watt
- Subjects
NTM ,Liver abscess ,Transplant recipient ,Mycobacterial disease ,Infectious and parasitic diseases ,RC109-216 - Abstract
Nontuberculous mycobacteria (NTM) are mycobacterial species other than Mycobacterium tuberculous and Mycobacterium leprae [1]. They are environmental organisms which have been implicated in a wide array of clinical syndromes. Here we describe a case of a Mycobacterium fortuitum complex liver abscess in a liver transplant recipient.
- Published
- 2023
- Full Text
- View/download PDF
25. The International thoracic organ transplant registry of the international society for heart and lung transplantation: Twenty-fifth pediatric heart transplantation report—2022; focus on infant heart transplantation.
- Author
-
Singh, Tajinder P., Cherikh, Wida S., Hsich, Eileen, Harhay, Michael O., Hayes, Don, Perch, Michael, Potena, Luciano, Sadavarte, Aparna, Zuckermann, Andreas, and Stehlik, Josef
- Subjects
- *
HEART transplantation , *TRANSPLANTATION of organs, tissues, etc. , *LUNG transplantation , *INFANTS - Published
- 2022
- Full Text
- View/download PDF
26. Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: A meta-analysis.
- Author
-
Yang, Mingyang, Li, Anthony, Wang, Yushu, Tran, Carolyn, Zhao, Siyi, and Ao, Guangyu
- Abstract
• Included studies compared the effect of monoclonal antibody therapy on clinical outcomes of organ transplant recipients with COVID-19. • A total of 8 articles comprising 930 organ transplant recipients with COVID-19 were included in the analysis. • Monoclonal antibody therapy significantly improve both severity and mortality among organ transplant recipients with COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. A Transplant Recipients International Organization Initiative to Improve Education About Posttransplant Cancer Risk, Prevention, and Treatment.
- Author
-
Gleason, James, Ho, Erica, Pines, Rachyl, Gregorowicz, Paula, Wood, Emily H., and Waterman, Amy D.
- Subjects
TUMOR prevention ,TUMOR risk factors ,TUMOR treatment ,HEALTH education ,ONLINE education ,PATIENTS ,RISK assessment ,HEALTH literacy ,DECISION making ,RESEARCH funding ,INTERNATIONAL agencies ,TRANSPLANTATION of organs, tissues, etc. - Abstract
The article evaluates the Post-Transplant Cancer project of the Transplant Recipients International Organization (TRIO) that consisted of the development of an educational website tailored for transplant recipients and aimed at improving education about post-transplant cancer risk, prevention and treatment.
- Published
- 2022
- Full Text
- View/download PDF
28. Impact of donor-to-recipient weight ratio on the hospital outcomes of pediatric heart transplantation.
- Author
-
Mahdavi, Mohammad, Tahouri, Tahmineh, Tabib, Avisa, Bakhshandeh, Hooman, Sadeghpour-Tabaei, Ali, Shahzadi, Hossein, and Harooni, Nader
- Abstract
Background: Identifying the factors that can influence the prognosis and final outcomes of pediatric heart transplantation is important and makes it possible to prevent complications and improve outcomes. Coordination of donor characteristics with the recipient in terms of sex, weight, body mass index (BMI), and body surface area (BSA) is an important factor that can influence the outcome of the transplantation. There is still no consensus regarding the role of discrepancy in anthropometrics between donors and recipients. The aim of this study was to investigate the relationship between donor and recipient weight mismatch on the early outcomes of pediatric heart transplantation. In this historical cohort study, 80 children who had underwent heart transplantation for the first time between 2014 and 2019 in Shahid Rajaie Cardiovascular Medical and Research Center in Tehran, Iran, were enrolled and divided into three groups according to donor-to-recipient weight ratio (0.8 < D/RW ≤ 1.5, 1.5 < D/RW ≤ 2.5, and 2.5 < D/RW). The early outcomes of transplantation, during the first post-transplant month, including right heart failure, renal failure, graft rejection, inotrope dependency, duration of intubation, length of ICU stay, death and requiring extracorporeal membrane oxygenation, were recorded through reviewing patient records. Results: Median donor-to-recipient BSA ratio was directly associated with higher vasoactive–inotropic score (P = 0.038), while no significant association was found between donor-to-recipient weight ratio and vasoactive–inotropic score (P = 0.07). No significant relationship was found between other outcomes and donor-to-recipient weight ratio or donor-to-recipient BSA ratio. Conclusions: Patients who require heart transplantation may also benefit from mismatch donors, especially in those with significant cardiomegaly. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
29. Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive Therapy.
- Author
-
Garcia Garrido, Hannah M., Vollaard, Albert, D'Haens, Geert R., Spuls, Phyllis I., Bemelman, Frederike J., Tanck, Michael W., de Bree, Godelieve J., Meek, Bob, Grobusch, Martin P., and Goorhuis, Abraham
- Subjects
IMMUNOSUPPRESSIVE agents ,PNEUMOCOCCAL vaccines ,IMMUNE response ,ADULTS ,VACCINE immunogenicity - Abstract
Immunosuppressive therapy increases the risk of pneumococcal disease. This risk can be mitigated by pneumococcal vaccination. The objective of this study was to investigate the immunogenicity of the 13-valent pneumococcal conjugate vaccine (PCV13), followed by the 23-valent pneumococcal polysaccharide vaccine (PPSV23), in adults with and without immunosuppressive therapy. We performed a prospective cohort study among adults using conventional immunomodulators (cIM), biological immunomodulators (bIM), combination therapy, and controls during 12 months. The primary outcome was seroprotection, defined as the proportion of patients with a postimmunization IgG concentration of ≥1.3 µg/mL for at least 70% (17/24) of the serotypes of PCV13 + PPSV23. We included 214 participants. For all 24 vaccine serotypes, IgG levels increased significantly in both treatment subgroups and controls, with peak seroprotection rates of 44% (combination therapy), 58% (cIM), 57% (bIM), and 82% (controls). By month 12, seroprotection had decreased to 24%, 48%, 39%, and 63%, respectively. Although pneumococcal vaccination with PCV13 + PPSV23 was immunogenic in all treatment groups, impaired vaccination responses were observed in patients using immunosuppressive medication. Apart from the obvious recommendation to administer vaccines before such medication is started, alternative vaccination strategies, such as additional PCV13 doses or higher-valent pneumococcal vaccines, should be investigated. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Development of predictive score for post-transplant survival based on pre-transplant recipient characteristics
- Author
-
Tai Yeon Koo, Joongyub Lee, and Jaeseok Yang
- Subjects
kidney transplantation ,prognosis ,survival ,transplant recipient ,Medical technology ,R855-855.5 - Abstract
Background : The new kidney allocation system in the United States has introduced longevity matching, which gives priority to allocating the best quality organs to wait-listed candidates with the longest predicted survival for the efficient utilization of organs that are of limited availability. The estimated post-transplant survival (EPTS) score was developed in the United States to risk-stratify all wait-listed patients. However, prognostic indices used in Western countries were derived from data that may be different for Korea and do not necessarily reflect prognostic values for Korean deceased donor kidney transplantation. Prognostic indices for Korean wait-listed candidates therefore need to be developed from Korean data. Methods : We analyzed 6,731 adult solitary kidney transplant patients for candidate risk prediction using the national data from the Korean Network for Organ Sharing (KONOS) and National Health Insurance Data Sharing Service (NHISS). Cox regression analysis was used to model the risk of patient death. Results : The Korean EPTS (K-EPTS) score was developed based on four recipient parameters (age, diabetes mellitus, hepatitis C virus, and duration of dialysis) that showed a significant association with post-transplant survival. K-EPTS scores showed good discrimination (C-statistics: 0.690; 95% confidence interval, 0.666–0.715). Moreover, the ability of the K-EPTS score to discriminate patient survival was better than that of the EPTS according to the criteria of the United Network for Organ Sharing (US-EPTS) score (P
- Published
- 2021
- Full Text
- View/download PDF
31. Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study
- Author
-
Paul M. McKeigue, David A. McAllister, David Caldwell, Ciara Gribben, Jen Bishop, Stuart McGurnaghan, Matthew Armstrong, Joke Delvaux, Sam Colville, Sharon Hutchinson, Chris Robertson, Nazir Lone, Jim McMenamin, David Goldberg, and Helen M. Colhoun
- Subjects
COVID-19/prevention and control ,Transplant recipient ,Nosocomial infection ,Matched case control Studies ,Medicine - Abstract
Abstract Background Clinically vulnerable individuals have been advised to shield themselves during the COVID-19 epidemic. The objectives of this study were to investigate (1) the rate ratio of severe COVID-19 associated with eligibility for the shielding programme in Scotland across the first and second waves of the epidemic and (2) the relation of severe COVID-19 to transmission-related factors in those in shielding and the general population. Methods In a matched case-control design, all 178,578 diagnosed cases of COVID-19 in Scotland from 1 March 2020 to 18 February 2021 were matched for age, sex and primary care practice to 1,744,283 controls from the general population. This dataset (REACT-SCOT) was linked to the list of 212,702 individuals identified as eligible for shielding. Severe COVID-19 was defined as cases that entered critical care or were fatal. Rate ratios were estimated by conditional logistic regression. Results With those without risk conditions as reference category, the univariate rate ratio for severe COVID-19 was 3.21 (95% CI 3.01 to 3.41) in those with moderate risk conditions and 6.3 (95% CI 5.8 to 6.8) in those eligible for shielding. The highest rate was in solid organ transplant recipients: rate ratio 13.4 (95% CI 9.6 to 18.8). Risk of severe COVID-19 increased with the number of adults but decreased with the number of school-age children in the household. Severe COVID-19 was strongly associated with recent exposure to hospital (defined as 5 to 14 days before presentation date): rate ratio 12.3 (95% CI 11.5 to 13.2) overall. The population attributable risk fraction for recent exposure to hospital peaked at 50% in May 2020 and again at 65% in December 2020. Conclusions The effectiveness of shielding vulnerable individuals was limited by the inability to control transmission in hospital and from other adults in the household. Mitigating the impact of the epidemic requires control of nosocomial transmission.
- Published
- 2021
- Full Text
- View/download PDF
32. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample
- Author
-
Hasan Irtiza, Rashid Tasnuva, Suliman Sarah, Amer Hatem, Chirila Razvan M., Mai Martin L., Jarmi Tambi, Khouzam Samir, Franco Pablo Moreno, Heilig Charles W., and Wadei Hani M.
- Subjects
coronavirus disease 2019 ,covid-19 ,severe acute respiratory syndrome coronavirus 2 ,sars-cov-2 ,novel coronavirus ,coronavirus pandemic ,renal transplant ,transplant recipient ,immunosuppression ,Internal medicine ,RC31-1245 - Abstract
Introduction. COVID-19 presents a special challenge to the kidney transplant population.
- Published
- 2021
- Full Text
- View/download PDF
33. COVID-19 safety measures at the Radiology Unit of a Transplant Institute: the non-COVID-19 patient's confidence with safety procedures.
- Author
-
Gerasia, Roberta, Mamone, Giuseppe, Amato, Santina, Cucchiara, Antonino, Gallo, Giuseppe Salvatore, Tafaro, Corrado, Fiorello, Giuseppe, Caruso, Calogero, and Miraglia, Roberto
- Abstract
Purpose: To support the wellbeing of both patients and their families, our aim was to investigate the satisfaction of non-COVID in- and out-patients regarding safety measures implemented at our radiology unit of a transplant institute against COVID infection. Materials and Methods: Over a five-month period, adult patients' feedback was obtained by a questionnaire on the fear of contracting COVID-19 during a radiology examination, the perceived delay in treatment, and the following safety measures implemented: modified schedules to limit the number of patients in the waiting area and to maximize social distancing; assistance by staff when visitors were not admitted; cleaning and disinfection of machines; mask wearing and hand hygiene of staff; and staff advice on hand hygiene and infection control precautions. Results: Over a five-month period, our preliminary results (387 patients) showed general patient satisfaction (99.1%) with safety measures applied at our radiology unit. Patients were satisfied with distancing and assistance by staff (100%), cleaning and disinfection (91%), mask wearing and hand hygiene of the staff (97%), and staff advice (94%). There was some criticism of the perceived delay in treatment (7.3%) and in the scheduling of the waiting list (5.4%), with 5.4% fearing contracting the virus. Patients' awareness of safety measures and confidence in the hospital preparedness policy was perceived by all interviewers, and 100% appreciated being questioned. Conclusion: The feedback given by the non-COVID patient helps to measure the quality in health care, to improve the quality service, and to protect and satisfy more vulnerable patients, also during the COVID-19 pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
34. Contraception: What to use after a solid-organ transplant?
- Author
-
Kunur Nikhilesh Shah, Sumesh Divakant Choudhary, Vineet V Mishra, and Rohina S Aggarwal
- Subjects
contraceptive methods ,medical eligibility criteria ,solid-organ transplant ,transplant recipient ,Biology (General) ,QH301-705.5 - Abstract
Solid-organ transplant increases the physical and mental well-being of women suffering from chronic kidney diseases. It also improves the menstrual and reproductive function of the transplant recipient, putting a woman at risk of unplanned pregnancy. Various contraceptive options are available to such women. According to the World Health Organization Medical Eligibility Criteria, almost all contraceptive methods belong to Category 2 for uncomplicated post-transplant recipients. For complicated renal-transplant patients, intra-uterine devices are Category 3/2, and combined hormonal contraceptives are Category 4. It is of paramount importance to discuss the pros and cons of each method, and this counselling should be included routinely before undergoing transplant surgery.
- Published
- 2021
- Full Text
- View/download PDF
35. Resolution of Cryptosporidiosis in Transplant Recipients: Review of the Literature and Presentation of a Renal Transplant Patient Treated With Nitazoxanide, Azithromycin, and Rifaximin.
- Author
-
Tomczak, Ewa, McDougal, April N, and White, A Clinton
- Abstract
Background Cryptosporidium is a major cause of diarrheal disease worldwide, including chronic disease in malnourished children and patients with acquired immune deficiency syndrome. There are increasing reports of cryptosporidiosis in transplant patients, especially from middle-income countries. Methods The literature on treatment of cryptosporidiosis in transplant patients was reviewed and included no controlled trials but only small case series. Nitazoxanide, azithromycin, spiramycin, and combination therapies have been used, but none are consistently efficacious. Results We present a case of chronic diarrhea from cryptosporidiosis in a renal transplant patient. His illness resolved with decreasing immunosuppression and treatment with the 3-drug combination of nitazoxanide, azithromycin, and rifaximin. Conclusions Although current therapies are not reliably effective in the absence of an effective cellular immune response, combination therapies hold promise for improved responses. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
36. Impact of recipient and donor smoking in living‐donor kidney transplantation: a prospective multicenter cohort study.
- Author
-
Jung, Hee‐Yeon, Jeon, Yena, Huh, Kyu Ha, Park, Jae Berm, Jung, Cheol Woong, Lee, Sik, Han, Seungyeup, Ro, Han, Yang, Jaeseok, Ahn, Curie, Cho, Jang‐Hee, Park, Sun‐Hee, Kim, Yong‐Lim, and Kim, Chan‐Duck
- Subjects
- *
KIDNEY transplantation , *COHORT analysis , *SMOKING - Abstract
Summary: The smoking status of kidney transplant recipients and living donors has not been explored concurrently in a prospective study, and the synergistic adverse impact on outcomes remains uncertain. The self‐reported smoking status and frequency were obtained from recipients and donors at the time of kidney transplantation in a prospective multicenter longitudinal cohort study (NCT02042963). Smoking status was categorized as "ever smoker" (current and former smokers collectively) or "never smoker." Among 858 eligible kidney transplant recipients and the 858 living donors, 389 (45.3%) and 241 (28.1%) recipients were considered ever smokers at the time of transplant. During the median follow‐up period of 6 years, the rate of death‐censored graft failure was significantly higher in ever‐smoker recipients than in never‐smoker recipients (adjusted HR, 2.82; 95% CI 1.01–7.87; P = 0.048). A smoking history of >20 pack‐years was associated with a significantly higher rate of death‐censored graft failure than a history of ≤20 pack‐years (adjusted HR, 2.83; 95% CI 1.19–6.78; P = 0.019). No donor smoking effect was found in terms of graft survival. The smoking status of the recipients and donors or both did not affect the rate of biopsy‐proven acute rejection, major adverse cardiac events, all‐cause mortality, or post‐transplant diabetes mellitus. Taken together, the recipient's smoking status before kidney transplantation is dose‐dependently associated with impaired survival. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. The Lived Experiences of Caregivers of Lung Transplant Recipients.
- Author
-
Glaze, Joy A., Brooten, Dorothy, Youngblut, Jo Anne, Hannan, Jean, and Page, Timothy
- Subjects
CAREGIVER attitudes ,RESEARCH ,DISEASE progression ,SERVICES for caregivers ,LUNG transplantation ,RESEARCH methodology ,INTERVIEWING ,EXPERIENCE ,QUALITATIVE research ,DESCRIPTIVE statistics ,HEALTH behavior ,JUDGMENT sampling ,CONTENT analysis ,THEMATIC analysis ,TRANSPLANTATION of organs, tissues, etc. ,BEHAVIOR modification - Abstract
Introduction: Lung transplantation is a treatment crucial for the survival of patients with end-stage lung diseases. An identified caregiver is obligatory for a patient to be eligible for a lung transplant and plays an essential role in the transplant recipient's care. Most caregiver research, however, has been on caregivers of persons with Alzheimer's disease or the elderly, with limited research on caregivers' experiences caring for transplant recipients. This study examined the experiences of caregivers of recipient's pre- and post-lung transplantation. Methods/Approach: Caregivers of lung transplant recipients were recruited using purposeful sampling. Audiotaped semi-structured open ended interviews were conducted until data saturation. Each interview was transcribed verbatim, and conventional content analysis performed to extract significant themes and subthemes. Findings: Four main themes and 12 sub-themes were identified. The former included (1) establishing the diagnosis, (2) caregiver roles, (3) caregiver psychological and psychosocial issues, and (4) support. Caregivers lacked basic knowledge related to lung transplantation. The caregivers' roles necessitated rearranging priorities, lifestyle changes, and redirecting emotional and physical energy. Support played an important role in caregiving experiences. Discussion: Each caregiver shared their unique caregiving experiences. Caregivers lack knowledge about transplantation, experience dramatic changes in their family life, social activities, employment, and often financial status. Healthcare providers can use the findings of this study in developing informational, and psychological interventions to alleviate caregivers' stress and anxiety. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
38. Psychological Characteristics of Recipients Pretransplantation in the Dallas UtErus Transplant Study (DUETS).
- Author
-
Warren, Ann Marie, McMinn, Kenleigh, Testa, Giuliano, Wall, Anji E., Saracino, Giovanna, Waddimba, Anthony C., and Johannesson, Liza
- Subjects
UTERINE surgery ,SCIENTIFIC observation ,CONFIDENCE intervals ,RESEARCH methodology ,RETROSPECTIVE studies ,HEALTH surveys ,INFERTILITY ,DYADIC Adjustment Scale ,PSYCHOSOCIAL factors ,QUALITY of life ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,RESEARCH funding ,TRANSPLANTATION of organs, tissues, etc. - Abstract
Introduction: Uterus transplantation is now a viable option for fertility treatment for women with absolute uterine factor infertility. Psychological assessment is recommended as a part of the perioperative evaluation process. Research Objective: The purpose of this study was to examine the psychological characteristics and mental health history of the 20 women who participated in the Dallas UtErus Transplant Study (DUETS) trial. Design: This retrospective observational descriptive study was part of a prospective clinical trial. Prior to transplant, 20 women completed a clinical psychological interview, 19 of whom also completed psychological assessment measures including the Hospital Anxiety and Depression Scale, Patient Health Questionnaire 9 item, Generalized Anxiety Disorder 7 item, PTSD Checklist for DSM-5, 36-Item Short Form, Connor-Davidson Resilience Scale 10 item, and Dyadic Adjustment Scale. Results: Women who participated in the trial had high health-related quality of life and minimal psychological history, with most reporting psychological distress associated with their initial infertility diagnosis (N = 13). None of the participants endorsed psychological distress to meet clinical concerns on the psychological measures used. Satisfaction with relationship adjustment with their partners was also high. Conclusions: Women with absolute uterine factor infertility who underwent uterus transplant demonstrated low psychological distress on assessment measures, were resilient, had high health related quality of life, and strong satisfaction with the quality of relationships with their partners. Although some women reported either current or past psychological diagnosis, most reported psychological distress that occurred at the time of the infertility diagnosis and appeared to resolve over time. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient
- Author
-
Sophie Gough, Scott Borgetti, and Christopher R. Fernandes
- Subjects
Infectious disease ,Cryptococcus ,Fungal disease ,Transplant recipient ,Transplant, medicine ,Orthostatic hypotension ,Infectious and parasitic diseases ,RC109-216 - Abstract
Background: Solid organ transplant recipients are immunocompromised and at risk for invasive viral, fungal, and bacterial pathogens. Cryptococcus neoformans is the third most common invasive fungal infection in transplant recipients, and the clinical presentation of Cryptococcus neoformans infection can vary widely. Cryptococcal disease can affect the brain, lungs, skin, or vasculature, and it is frequently disseminated. Meningitis typically presents with fever, headache, and altered mental status. Solid organ transplant recipients with cryptococcosis tend to have poorer outcomes than HIV patients with cryptococcosis. Case presentation: In this case report, we describe the case of a 69 year-old man with a past medical history of a deceased donor kidney transplant who presented with severe orthostatic hypotension and was found to have disseminated cryptococcosis. Conclusions: This case report emphasizes the importance of broadening the differential diagnosis in transplant recipients who present with non-specific chief concerns. Availability of data and materials: No datasets were used in the preparing of this manuscript. All patient information comes from the electronic health record and authors personal care of this patient.
- Published
- 2022
- Full Text
- View/download PDF
40. Folate Deficiency and Medication-Induced Severe Pancytopenia in a Bilateral Lung Transplantee.
- Author
-
Au-Yeung NM, Regennitter NS, Stepherson J, Seele J, Rosenblatt E, and Carter W
- Abstract
Folate is a water-soluble vitamin that is essential to DNA synthesis and replication. Its deficiency is a leading cause of megaloblastic anemia, which is often asymptomatic but can present with nonspecific symptoms, such as fatigue and lightheadedness. Folate deficiency can rarely present with pancytopenia, which has been described in past case reports but even more scarcely in transplant recipients. We present a 74-year-old bilateral lung transplantee who presented with presyncope and was found to have severe pancytopenia with folate deficiency during the initial workup. Some medications, including mycophenolate mofetil, valganciclovir, and posaconazole were held. Peripheral blood smear showed blastoid cells, but follow-up imaging and flow cytometry negated any concern for a malignant process. Bone marrow biopsy showed an extremely hypocellular marrow with marked trilineage hypoplasia. He required blood product transfusions, but his admission was overall uneventful with no life-threatening sequelae. His blood counts improved with folate replacement and discontinuation of offending medications. He was discharged after nine days in stable condition. Two months later, he experienced a milder and self-limited recurrence of pancytopenia with normal folate and cobalamin levels., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Au-Yeung et al.)
- Published
- 2024
- Full Text
- View/download PDF
41. Limits of the Glasgow Coma Scale When Assessing for Sepsis in Allogeneic Hematopoietic Cell Transplant Recipients.
- Author
-
Lind, Margaret L., Maravilla Rosas, Mirta, McFarland, Lindsay, Taylor, Lenise, Olson, Sandra, and Pergam, Steven A.
- Subjects
- *
PREDICTIVE tests , *RETROSPECTIVE studies , *FISHER exact test , *SEPSIS , *PSYCHOSOCIAL factors , *GLASGOW Coma Scale , *RESEARCH funding , *HEMATOPOIETIC stem cell transplantation , *STATISTICAL sampling , *ELECTRONIC health records , *TRANSPLANTATION of organs, tissues, etc. - Abstract
Background: The well-documented association between acute mental status changes and sepsis development and progression makes acute mental status an attractive factor for sepsis screening tools. However, the usefulness of acute mental status within these criteria is limited to the frequency and accuracy of its capture. The Glasgow Coma Scale (GCS) score--the acute mental status indicator in many clinical sepsis criteria--is infrequently captured among allogeneic hematopoietic cell transplant recipients with suspected infections, and its ability to serve as an indicator of acute mental status among this high-risk population is unknown. Objective: We evaluated the GCS score as an indicator of acute mental status during the 24 hours after suspected infection onset among allogeneic hematopoietic cell transplant recipients. Methods: Using data from the first 100 days posttransplant for patients transplanted at a single center between September 2010 and July 2017, we evaluated the GCS score as an indicator of documented acutemental status during the 24 hours after suspected infection onset. From all inpatients with suspected infections, we randomly selected a cohort based on previously published estimates of GCS score frequency among hematopoietic cell transplant recipients with suspected infections and performed chart review to ascertain documentation of clinical acute mental status within the 24 hours after suspected infection onset. Results: A total of 773 patients had ≥1 suspected infections and experienced 1,655 suspected infections during follow-up--625 of which had an accompanying GCS score. Among the randomly selected cohort of 100 persons with suspected infection, 28 were accompanied with documented acute mental status, including 18 without a recorded GCS. In relation to documented acute mental status, the GCS had moderate to high sensitivity and high specificity. Discussion: These data indicate that, among allogeneic hematopoietic cell transplant recipients with suspected infections, the GCS scores are infrequently collected and have a moderate sensitivity. If sepsis screening tools inclusive of acute mental status changes are to be used, nursing teams need to increasemeasurement of GCS scores among high sepsis risk patients or identify a standard alternative indicator. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
42. Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients.
- Author
-
Johnson, Tanner M, Howard, Amanda H, Miller, Matthew A, Allen, Lorna L, Huang, Misha, Molina, Kyle C, and Bajrovic, Valida
- Subjects
- *
CLOSTRIDIOIDES difficile , *HEART failure , *DISEASE relapse , *PATIENT readmissions , *TRANSPLANTATION of organs, tissues, etc. - Abstract
Background Bezlotoxumab significantly reduces the incidence of recurrent Clostridioides difficile infection (CDI); however, limited data are available in solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. Methods We conducted a single-center retrospective analysis comparing recurrent CDI in SOT and HCT recipients receiving standard of care alone (oral vancomycin, fidaxomicin, or metronidazole) or bezlotoxumab plus standard of care. The primary outcome was 90-day incidence of recurrent CDI, and secondary outcomes included 90-day hospital readmission, mortality, and incidence of heart failure exacerbation. Results Overall, 94 patients received bezlotoxumab plus standard of care (n = 38) or standard of care alone (n = 56). The mean age was 53 years; patients had a median of 3 prior Clostridioides difficile episodes and 4 risk factors for recurrent infection. Most patients were SOT recipients (76%), with median time to index CDI occurring 2.7 years after transplantation. Ninety-day recurrent CDI occurred in 16% (6/38) in the bezlotoxumab cohort compared to 29% (16/56) in the standard of care cohort (P = .13). Multivariable regression revealed that bezlotoxumab was associated with significantly lower odds of 90-day recurrent CDI (odds ratio, 0.28 [95% confidence interval,.08–.91]). There were no differences in secondary outcomes, and no heart failure exacerbations were observed. Conclusions In a cohort of primarily SOT recipients, bezlotoxumab was well tolerated and associated with lower odds of recurrent CDI at 90 days. Larger, prospective trials are needed to confirm these findings among SOT and HCT populations. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
43. Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study.
- Author
-
McKeigue, Paul M., McAllister, David A., Caldwell, David, Gribben, Ciara, Bishop, Jen, McGurnaghan, Stuart, Armstrong, Matthew, Delvaux, Joke, Colville, Sam, Hutchinson, Sharon, Robertson, Chris, Lone, Nazir, McMenamin, Jim, Goldberg, David, and Colhoun, Helen M.
- Subjects
- *
COVID-19 , *COVID-19 pandemic , *CASE-control method , *PRIMARY care , *ADULTS - Abstract
Background: Clinically vulnerable individuals have been advised to shield themselves during the COVID-19 epidemic. The objectives of this study were to investigate (1) the rate ratio of severe COVID-19 associated with eligibility for the shielding programme in Scotland across the first and second waves of the epidemic and (2) the relation of severe COVID-19 to transmission-related factors in those in shielding and the general population.Methods: In a matched case-control design, all 178,578 diagnosed cases of COVID-19 in Scotland from 1 March 2020 to 18 February 2021 were matched for age, sex and primary care practice to 1,744,283 controls from the general population. This dataset (REACT-SCOT) was linked to the list of 212,702 individuals identified as eligible for shielding. Severe COVID-19 was defined as cases that entered critical care or were fatal. Rate ratios were estimated by conditional logistic regression.Results: With those without risk conditions as reference category, the univariate rate ratio for severe COVID-19 was 3.21 (95% CI 3.01 to 3.41) in those with moderate risk conditions and 6.3 (95% CI 5.8 to 6.8) in those eligible for shielding. The highest rate was in solid organ transplant recipients: rate ratio 13.4 (95% CI 9.6 to 18.8). Risk of severe COVID-19 increased with the number of adults but decreased with the number of school-age children in the household. Severe COVID-19 was strongly associated with recent exposure to hospital (defined as 5 to 14 days before presentation date): rate ratio 12.3 (95% CI 11.5 to 13.2) overall. The population attributable risk fraction for recent exposure to hospital peaked at 50% in May 2020 and again at 65% in December 2020.Conclusions: The effectiveness of shielding vulnerable individuals was limited by the inability to control transmission in hospital and from other adults in the household. Mitigating the impact of the epidemic requires control of nosocomial transmission. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
44. Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.
- Author
-
Diaz, Natalia A., Ambrosioni, Juan, Tuset, Montserrat, Brunet, Mercé, Cofan, Frederic, Crespo, Gonzalo, Ruiz, Pablo, Redondo-Pachón, Dolores, Crespo, Marta, Marín-Casino, Mónica, Moreno, Asunción, and Miró, José M.
- Subjects
- *
TACROLIMUS , *RAPAMYCIN , *HIV-positive persons , *EVEROLIMUS , *IMMUNOSUPPRESSIVE agents - Abstract
People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT represents a major challenge due to the potential drug-drug interactions between antiretroviral drugs and immunosuppressive agents, particularly when resorting to antiretroviral drugs that require pharmacokinetic enhancers. We report three cases of cobicistat-tacrolimus co-administration, two of which also include the co-administration of mTOR inhibitors, in HIV-positive patients undergoing SOT (2 kidney and 1 liver recipient). We review previously reported cases and provide recommendations for initial management following transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
45. Disseminated Trichosporon asahii infection in a combined liver‐kidney transplant recipient successfully treated with voriconazole
- Author
-
Ranjit Sah, Arbindra singh Soin, Sony Chawla, Teena Wadhwa, and Neha Gupta
- Subjects
combined liver‐kidney transplant ,immunocompromised hosts ,transplant recipient ,Trichosporon asahii ,voriconazole ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Abstract Introduction Trichosporon asahii is an emerging cause of systemic fungal infection in an immunocompromised host. Several life threatening disseminated T. asahii infection in single solid organ (liver or kidney) transplant recipients, in neutropenic and hematological malignancy patients have been reported. Case presentation (Methods and Results) A 49‐year old gentleman who underwent simultaneous living‐donor liver transplantation (donor sister) and kidney transplant (donor wife) developed fever and subsegmental patchy consolidation with right sided pleural effusion on fourth postoperative day. Central line blood stream infection was suspected. Blood culture grew creamy white colonies of T. asahii on blood agar with characteristic dirty‐green colonies on CHROMagar. Laboratory analysis of pleural fluid also revealed budding yeast cells identified as T. asahii. Microscopy of the isolates showed hyphae, arthroconidia, and blastospores. The isolates were identified as T. asahii by VITEK MS which uses matrix‐assisted laser desorption/ionization time‐of‐flight (MALDI‐TOF) technology. Initially liposomal amphotericin B and micafungin was initiated, but due to lack of clinical and microbiological response, patient was switched to voriconazole. Simultaneously, tacrolimus doses were reduced to one‐third in view of interaction with voriconazole. Subsequently, patient improved with resolution of fever and microbiological cure. Conclusion This is the first case report of disseminated T. asahii infection in a combined liver‐kidney transplant recipient successfully treated with voriconazole. Azole antifungal are the promising drug of choice for systemic T. asahii infection. Drug interactions should be considered while using these antifungal agents.
- Published
- 2019
- Full Text
- View/download PDF
46. Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive Therapy
- Author
-
Hannah M. Garcia Garrido, Albert Vollaard, Geert R. D’Haens, Phyllis I. Spuls, Frederike J. Bemelman, Michael W. Tanck, Godelieve J. de Bree, Bob Meek, Martin P. Grobusch, and Abraham Goorhuis
- Subjects
pneumococcal vaccination ,immunocompromised host ,transplant recipient ,autoimmune disease ,vaccine immunogenicity ,Medicine - Abstract
Immunosuppressive therapy increases the risk of pneumococcal disease. This risk can be mitigated by pneumococcal vaccination. The objective of this study was to investigate the immunogenicity of the 13-valent pneumococcal conjugate vaccine (PCV13), followed by the 23-valent pneumococcal polysaccharide vaccine (PPSV23), in adults with and without immunosuppressive therapy. We performed a prospective cohort study among adults using conventional immunomodulators (cIM), biological immunomodulators (bIM), combination therapy, and controls during 12 months. The primary outcome was seroprotection, defined as the proportion of patients with a postimmunization IgG concentration of ≥1.3 µg/mL for at least 70% (17/24) of the serotypes of PCV13 + PPSV23. We included 214 participants. For all 24 vaccine serotypes, IgG levels increased significantly in both treatment subgroups and controls, with peak seroprotection rates of 44% (combination therapy), 58% (cIM), 57% (bIM), and 82% (controls). By month 12, seroprotection had decreased to 24%, 48%, 39%, and 63%, respectively. Although pneumococcal vaccination with PCV13 + PPSV23 was immunogenic in all treatment groups, impaired vaccination responses were observed in patients using immunosuppressive medication. Apart from the obvious recommendation to administer vaccines before such medication is started, alternative vaccination strategies, such as additional PCV13 doses or higher-valent pneumococcal vaccines, should be investigated.
- Published
- 2022
- Full Text
- View/download PDF
47. A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
- Author
-
Tsung, Irene, Worden, Francis P., and Fontana, Robert J.
- Subjects
CANCER patients ,DRUG efficacy ,IMMUNOTHERAPY ,MEDICAL records ,METASTASIS ,HEAD & neck cancer ,PATIENT safety ,SKIN tumors ,SQUAMOUS cell carcinoma ,STEROIDS ,TRANSPLANTATION of organs, tissues, etc. ,PILOT projects ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,ACQUISITION of data methodology ,IMMUNE checkpoint inhibitors ,THERAPEUTICS - Abstract
Background: Immune checkpoint inhibitors (ICIs) are increasingly used in various solid organ malignancies. However, there are limited data regarding their safety and efficacy in solid organ transplant (SOT) recipients. The aim of this study was to review our experience with ICIs in SOT recipients with advanced head and neck cutaneous squamous cell carcinoma (cSCC). Methods: A retrospective review of ICIs used in SOT recipients from April 2011 to September 2019 was undertaken. Patient clinical and demographic features, ICI regimen, immunosuppression, treatment efficacy, and adverse events were reviewed. Results: The seven SOT recipients (four kidney, two liver, one lung) were diagnosed with metastatic head and neck cSCC. All had undergone prior locoregional surgery and adjuvant radiation therapy. At a median of 10.8 years (range, 6.6–18.1) post‐transplant, six were treated with cemiplimab and one with pembrolizumab after minimizing calcineurin inhibitors (CNIs) or conversion of CNI to mammalian target of rapamycin (mTOR) inhibitors. During a median follow‐up of 7.1 months, overall tumor response rate was 57.1% with one complete responder and three partial responders. Four patients died at a median of 135 days after starting ICI with two dying from tumor progression and two dying from other causes. Regarding adverse events, one lung transplant recipient developed severe pneumonitis that resolved with high‐dose steroids, and one renal transplant patient developed progressive renal injury and died of unrelated causes. The three patients who received prophylactic prednisone all responded to cemiplimab with preserved allograft function and no adverse events. Conclusion: Our data suggest that minimization of CNI and conversion of CNI to mTOR inhibitors along with judicious use of prophylactic steroids may allow for the safe use of ICIs in SOT recipients with advanced cSCC. Short‐term efficacy appears promising, but prospective studies with further follow‐up and a standardized protocol for prophylactic steroids are needed. Implications for Practice: Solid organ transplant (SOT) recipients are at increased risk of developing malignancy because of long‐term post‐transplant immunosuppression. Although immune checkpoint inhibitors (ICIs) are increasingly shown to be successful in treating multiple types of cancer, SOT recipients have been excluded from clinical trials because of concerns regarding potential allograft rejection. This pilot study provides evidence that ICIs along with prophylactic steroids may be a safe and efficacious treatment option for selected SOT recipients with advanced cutaneous squamous cell carcinoma. However, further prospective studies using ICIs in this high‐risk patient population are needed. This article focuses on the safety and efficacy of immune checkpoint inhibitors in solid organ transplant recipients with advanced head and neck cutaneous squamous cell carcinoma who have failed attempts at immunosuppression minimization, as well as prior surgical, radiation therapy, and other systemic therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
48. Patient Experiences of World Transplant Games 2023.
- Author
-
Mitchell, Jade
- Subjects
GIFT giving ,TERMINALLY ill ,PATIENTS ,GAMES ,CYSTIC fibrosis ,PATIENTS' attitudes ,EXPERIENCE ,ADULT respiratory distress syndrome ,ATTITUDES toward illness ,ORGAN donation ,TRANSPLANTATION of organs, tissues, etc. - Published
- 2023
- Full Text
- View/download PDF
49. Incidental Lung Cancer of Explanted Lungs from Lung Transplant Recipients: Incidence, Characteristics, and 5-Year Survival.
- Author
-
Yong Jun Choi, Song Yee Kim, Moo Suk Park, Jin Gu Lee, Hyo Chae Paik, and Sang Hoon Lee
- Abstract
Purpose: Recent history of malignancy without 5-year disease-free interval is an absolute contraindication for lung transplantation (LTx). However, in rare cases, lung cancer may be incidentally diagnosed in the explanted lung of recipients. We evaluated the prevalence, 5-year survival, and prognosis of incidental lung cancer after LTx. Materials and Methods: Medical records of patients who underwent LTx at Severance Hospital between January 1, 2012 and June 30, 2019 were reviewed. Patients with incidental lung cancer were included, and those with histologically proven pre-transplant lung cancer were excluded. Results: Of the 247 patients who underwent LTx, 6 (2.4%) were diagnosed with incidental lung cancer. Interstitial lung disease (ILD) was the underlying lung disease in all patients. The median interval from the last preoperative computed tomography (CT) screening to LTx was 26 days. The most common histological type of incidental lung cancer was adenocarcinoma (n=4, 66.7%). All Stage IV cases were misdiagnosed as fibrosis on preoperative chest CT. Patients with incidental lung cancer showed lower 5-year survival than those without malignancy (median survival: 8.5 months vs. not reached, p=0.047, respectively). Patients with Stage III or IV demonstrated lower 5-year survival than those with Stage I or II and those without malignancy (median survival: 5 months, 19 months, and not reached, respectively, p=0.011). Conclusion: Multidisciplinary preoperative screening and serial imaging studies within short intervals are required to differentiate lung malignancy from fibrotic foci. Furthermore, active pathologic examination of suspicious lung lesions is required in patients at high risk for lung cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
50. Adherence to Human Colon Cells by Multidrug Resistant Enterobacterales Strains Isolated From Solid Organ Transplant Recipients With a Focus on Citrobacter freundii
- Author
-
José Ramos-Vivas, Itziar Chapartegui-González, Marta Fernández-Martínez, Claudia González-Rico, John Barrett, Jesús Fortún, Rosa Escudero, Francesc Marco, Laura Linares, Javier Nieto, Maitane Aranzamendi, Patricia Muñoz, Maricela Valerio, Jose María Aguado, Fernando Chaves, Irene Gracia-Ahufinger, Aurora Paez-Vega, Luis Martínez-Martínez, and María Carmen Fariñas
- Subjects
Enterobacterales ,Citrobacter ,epithelial cells ,virulence factors ,bacterial adherence ,transplant recipient ,Microbiology ,QR1-502 - Abstract
Enterobacteria species are common causes of hospital-acquired infections, which are associated with high morbidity and mortality rates. Immunocompromised patients such as solid organ transplant (SOT) recipients are especially at risk because they are frequently exposed to antibiotics in the course of their treatments. In this work, we used a collection of 106 Escherichia coli, 78 Klebsiella pneumoniae, 25 Enterobacter spp., and 24 Citrobacter spp. multidrug resistant strains isolated from transplant patients (hepatic, renal or renal/pancreatic) in order to examine their ability to adhere in vitro to HT-29 human colon cells, and to determine if some adhesive characteristics are associated with prevalence and persistence of these strains. A total of 33 E. coli (31%), 21 K. pneumoniae (27%), 7 Enterobacter spp. (28%), and 5 Citrobacter spp. (21%), adhered to the colon epithelial cells. Two main adherence patterns were observed in the four species analyzed, diffuse adherence, and aggregative adherence. Under transmission electronic microscopy (TEM), most bacteria lacked visible fimbria on their surface, despite their strong adherence to epithelial cells. None of the strains studied was able to induce any cytotoxic effect on HT-29 cells although some of them strongly colonizing both cells and glass coverslips at high density. Some of the strains failed to adhere to the epithelial cells but adhered strongly to the cover-slide, which shows that microscopy studies are mandatory to elucidate the adherence of bacteria to epithelial cells in vitro, and that quantitative assays using colony forming unit (CFUs) counting need to be supplemented with pictures to determine definitively if a bacterial strain adheres or not to animal cells in vitro. We report here, for the first time, the aggregative adherence pattern of two multidrug resistant (MDR) Citrobacter freundii strains isolated from human patients; importantly, biofilm formation in Citrobacter is totally dependent on the temperature; strong biofilms were formed at room temperature (RT) but not at 37°C, which can play an important role in the colonization of hospital surfaces. In conclusion, our results show that there is a great variety of adhesion phenotypes in multidrug-resistant strains that colonize transplanted patients.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.